SARS-CoV-2 variants and ending the COVID-19 pandemic

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

(2021) Denis Y Logunov et al.   LANCET

South Africa suspends use of AstraZeneca’s COVID-19 vaccine after it fails to clearly stop virus variant

(2021) Jon Cohen   SCIENCE

Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa

(2021) Meredith Wadman   SCIENCE

One-dose COVID-19 vaccine offers solid protection against severe disease

(2021) Jon Cohen   SCIENCE

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

(2021) Alexander Muik et al.   SCIENCE

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

How COVID vaccines are being divvied up around the world

(2020) Asher Mullard   NATURE

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE